Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

379

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

June 2, 2025

Study Completion Date

August 31, 2025

Conditions
Sickle Cell Disease
Interventions
BEHAVIORAL

Guided Relaxation

Guided relaxation uses the mind to reduce pain, promote well-being, and improve physical function. Guided relaxation is a state of concentration and focused attention that gives people more control over their pain experience and its impact and an increased sense of well-being.

OTHER

Acupuncture

Acupuncture is a body-based therapy that includes the insertion of thin needles at strategic points on the body that has been proven effective for reducing pain.

Trial Locations (5)

21218

Johns Hopkins University, Baltimore

22710

Duke University, Durham

30322

Emory University, Atlanta

32610

University of Florida, Gainesville

60612

University of Illinois at Chicago, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Florida

OTHER

collaborator

Duke University

OTHER

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of Illinois at Chicago

OTHER

NCT04906447 - Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain | Biotech Hunter | Biotech Hunter